It has been reported that the abnormal expression of CRABP2 is closely related to the development of neuroblastoma, Wilms tumor, head and neck squamous cell carcinoma, and non-small-cell lung cancer [21–23]. Here, CRABP2 is linked to head and neck squamous cell carcinoma.